Pfizer, Inc. Voluntary Nationwide Recall of One Lot of Children's Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle

PUBLISHED: Aug 28, 2018
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Medical Office, Pharmacy, Rural Health Clinics

Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling one lot of Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ Bottle because of customer complaints that the dosage cup provided is marked in teaspoons and the instructions on the label are described in milliliters (mL).

Pfizer concluded that the use of the product with an unmatched dosage cup marked in teaspoons rather than milliliters has a chance of being associated with potential overdose. The most common symptoms associated with ibuprofen overdose include nausea, vomiting, headache, drowsiness, blurred vision and dizziness.

Recalled Lot Information:

Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ Bottle, NDC 0573-0207-30, lot R51129 distributed nationwide to wholesalers, distributors and retailers in the United States from May 2018 through June 2018.

Follow the link below for additional information.

Want to read the full alert and receive alert emails?

Browse Additional Alerts